*Some Market data delayed by 15 mins.

NeoGenomics, Inc.

Symbol: NEO (NASDAQ)
5.16 ▲ (6.51%) 0.315

Company Description:
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Key Stats
  • Today's Open: $5.195
  • Today's High: $5.254
  • Today's Low: $5.117
  • Today's Volume: 2.07M
  • Yesterday Close: $4.84
  • Yesterday High: $5.11
  • Yesterday Low: $4.78
  • Yesterday Volume: 4.40M
  • Last Min Volume: 600
  • Last Min High: $5.155
  • Last Min Low: $5.155
  • Last Min VWAP: $5.155
Company Profile
  • Name: NeoGenomics, Inc.
  • Website: https://www.neogenomics.com
  • Listed Date: 1996-01-25
  • Location: FORT MYERS, FL
  • Market Status: Active
  • CIK Number: 0001077183
  • SIC Code: 8734
  • SIC description: SERVICES-TESTING LABORATORIES
  • Market Cap: $666.56M
  • Round Lot: 100
  • Outstanding Shares: 129.18M
  • Asset Type: CS
RECENT FILINGS FOR NEO
Filing Date Filing Type Format
2025-07-29 10-Q View
2025-07-29 8-K View
2025-07-17 SCHEDULE 13G/A View
2025-06-24 4 View
2025-06-24 3 View
2025-06-24 8-K View
2025-06-16 S-8 View
2025-06-03 4/A View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-06-03 4 View
2025-05-28 4 View
2025-05-27 8-K View
2025-05-14 SCHEDULE 13G/A View
Latest News on NEO

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.